EQRx is a new type of pharmaceutical company committed to developing and delivering innovative medicines for some of the most prevalent disease areas, including cancer and immune-inflammatory conditions.
Overview
Founded2019
TypePublic
Longevity relatedYes
LocationCambridge, Massachusetts, USA
Latest News
Should You Buy EQRx (EQRX) Ahead of Earnings?Aug 09, 2023Zacks Investment Research
EQRx (EQRX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Eliem (ELYM) to Explore Strategic Options, Stock Rises 6%Jul 21, 2023Zacks Investment Research
Eliem (ELYM) announces its decision to halt its Kv7 development program in its quest to explore strategic alternatives. The stock of the company rises 6%...